It's all in your brain
Launching Lutea™ - and how it's different to Nettle™
We’re thrilled to introduce Lutea™ - our newest product, and our first release in the United States. Lutea™ is built on the same scientific foundation as Nettle™, but it represents a new perspective on how we think about women’s brain health, daily wellbeing, and self-care.
We asked Nettle™ users about their experience - here’s what they said
Real women, real results. After six months with Nettle™, users reported fewer sick days, less reliance on medication, and reduced GP visits. 80% said they regained nearly a month of life each year, 9 in 10 changed how they use painkillers or hormones, and over half wish GPs offered Nettle™ first. Proof that menstrual health can mean fewer pills, fewer appointments - and more control.
ENDO-205: the first non-hormonal endometriosis treatment enters clinical trials
The FDA cleared the first non-hormonal drug candidate for endometriosis to enter clinical trials. We explain what ENDO-205 is, why non-hormonal options matter, and what else is in the pipeline for people who can't or won't take hormonal treatments.
ADHD, contraception, and the risk no one talks about
Executive dysfunction undermines the daily routines reliable contraception depends on, yet the research linking ADHD to higher unintended pregnancy risk is largely absent from clinical guidance. What the evidence shows, the drug interaction no one flags, and what better care looks like.
Why the care you need doesn't exist yet
Integrated ADHD and reproductive health care doesn't exist yet, and the reason is an evidence gap, not a clinical one. The clinical case is building; the economic case has barely been made. What it would take to build it, and how to advocate in the meantime.
Lost years: how ADHD's diagnostic delay costs women their reproductive health
Women are diagnosed with ADHD 10 to 13 years later than men, and that delay lands squarely on the years when PMDD, contraception, and postpartum risk peak. How diagnostic overshadowing works, what it costs, and what changes at diagnosis.
The research gap that's leaving women with ADHD behind
Women with ADHD show far higher rates of PMDD and postpartum depression, yet ADHD research and reproductive health research were built around different populations and rarely connect. A look at the biology, the missing economic case, and what integrated care would measure.
Can brain stimulation reduce how often migraines happen?
New evidence suggests that targeting the brain's electrical activity, rather than treating each attack after the fact, can reduce migraine frequency for some people. Here's what the research shows and why it matters.